BEMPEDOIC ACID / EZETIMIBE (Nustendi®)

Clinical Indication

Primary hypercholesterolaemia or mixed dyslipidaemia and secondary prevention in adults

Comments

In line with the LLR lipid guidance

 

Date of classification

September 2022

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.